0.00Open0.00Pre Close0 Volume0 Open Interest84.00Strike Price0.00Turnover7589.95%IV-19.40%PremiumNov 1, 2024Expiry Date13.65Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9384Delta0.0155Gamma5.08Leverage Ratio-580.0457Theta0.0000Rho-4.77Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet